SCHEMBL31467390

SCHEMBL31467390

COc1ccc(-c2c(-c3ccccc3F)nc(-c3ccccc3F)n2-n2c(-c3ccccc3F)nc(-c3ccccc3)c2-c2ccccc2)cc1OC

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.50
PDE4A P27815 1/20 0.45
ADORA1 P30542 1/20 0.44
ACACA Q13085 1/20 0.44
MEN1 O00255 5/20 0.42
KMT2A Q03164 5/20 0.42
ALDH1A1 P00352 5/20 0.42
KDM4E B2RXH2 4/20 0.42
HSD17B10 Q99714 3/20 0.42
MAPT P10636 4/20 0.41
LMNA P02545 3/20 0.41
TP53 P04637 2/20 0.41
POLB P06746 1/20 0.41
HPGD P15428 2/20 0.41
TSHR P16473 2/20 0.41
USP2 O75604 1/20 0.41
MAPK1 P28482 1/20 0.41
HTT P42858 1/20 0.41
ATM Q13315 1/20 0.41
SMN1; SMN2 Q16637 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL62627 0.84 L3MBTL1 (0.50) L3MBTL1PDE4AADORA1ACACAMEN1
SCHEMBL29373643 0.84 L3MBTL1 (0.50) L3MBTL1PDE4AADORA1ACACAMEN1
SCHEMBL6362343 0.82 ADORA2A (0.42) L3MBTL1ADORA1MEN1KMT2AKDM4E
SCHEMBL7897274 0.80 L3MBTL1 (0.53) L3MBTL1PDE4AADORA1ACACAMEN1
SCHEMBL29732925 0.80 L3MBTL1 (0.53) L3MBTL1PDE4AADORA1ACACAMEN1
SCHEMBL6360563 0.78 ALDH1A1 (0.59) L3MBTL1ADORA1ALDH1A1KDM4ELMNA
SCHEMBL31467270 0.78 ALDH1A1 (0.59) L3MBTL1ADORA1ALDH1A1KDM4ELMNA
SCHEMBL7044209 0.78 NPC1 (0.54) L3MBTL1PDE4AACACAMEN1KMT2A
SCHEMBL23524454 0.75 L3MBTL1 (0.45) L3MBTL1PDE4AADORA1ACACAMEN1
SCHEMBL28767208 0.73 ALDH1A1 (0.54) L3MBTL1PDE4AACACAMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260147277-A1 TRANSFER FILM, PATTERN FORMING METHOD, LAMINATE, AND SEMICONDUCTOR PACKAGE FUJIFILM CORPORATION (JP) 2026-05-28 US disclosed
WO-2025105281-A1 PHOTOSENSITIVE COMPOSITION, TRANSFER FILM, LAMINATE PRODUCTION METHOD, LAMINATE, AND SEMICONDUCTOR PACKAGE 富士フイルム株式会社 2025-05-22 WO disclosed
WO-2025047730-A1 TRANSFER FILM, PATTERN FORMATION METHOD, LAMINATE, SEMICONDUCTOR PACKAGE 富士フイルム株式会社 2025-03-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260147277-A1 TRANSFER FILM, PATTERN FORMING METHOD, LAMINATE, AND SEMICONDUCTOR PACKAGE LCP1, PCNA, FDFT1 L3MBTL1 1916/4885PDE4A 4234/4885ADORA1 4261/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.